PTP4A3 phosphatase is a novel drug target for epithelial ovarian cancer.

被引:0
|
作者
Cornelison, John Robert [1 ]
Rastelli, Ettore J. [2 ]
Hart, Duncan J. [3 ]
Mendelson, Anna J. [3 ]
Sharlow, Elizabeth R. [3 ]
Wipf, Peter [2 ]
Lazo, John S. [3 ]
机构
[1] KeViRx Inc, Charlottesville, VA USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] Univ Virginia, Charlottesville, VA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1459
引用
收藏
页数:2
相关论文
共 50 条
  • [41] A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3)
    Dylan R. Rivas
    Mark Vincent C. Dela Cerna
    Caroline N. Smith
    Shilpa Sampathi
    Blaine G. Patty
    Donghan Lee
    Jessica S. Blackburn
    [J]. Scientific Reports, 11
  • [42] A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion
    McQueeney, Kelley E.
    Salamoun, Joseph M.
    Ahn, Jennifer G.
    Pekic, Paula
    Blanco, Isabella K.
    Struckman, Heather L.
    Sharlow, Elizabeth R.
    Wipf, Peter
    Lazo, John S.
    [J]. FASEB JOURNAL, 2018, 32 (10): : 5661 - 5673
  • [43] PTP4A3 expression associated with increased invasion in esophageal adenocarcinoma
    Wang, Zhuwen
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [44] PTP4A3 OVEREXPRESSION PREDICTS CLINICAL AGGRESSIVENESS IN UROTHELIAL CARCINOMA
    Yeh, H-C.
    Wu, W-J.
    Huang, C-N.
    Li, C-C.
    Ke, H-L.
    Li, W-M.
    Li, C-F.
    Lee, Y-Y.
    Lin, H-H.
    Yeh, B-W.
    Hwang, S-J.
    Liang, P-I.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : E42 - E43
  • [45] Potential targets of PTP4A3 involved in uveal melanoma migration
    Liot, Geraldine
    Anezo, Oceane
    Laurent, Cecile
    Maacha, Selma
    Planque, Nathalie
    Saule, Simon
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [46] A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3)
    Rivas, Dylan R.
    Dela Cerna, Mark Vincent C.
    Smith, Caroline N.
    Sampathi, Shilpa
    Patty, Blaine G.
    Lee, Donghan
    Blackburn, Jessica S.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [47] IRAK1: A novel TOLLway to target ovarian cancer.
    Standing, David
    Gunewardena, Sumedha
    Sayed, Afreen A.
    Pritchard, Michele T.
    Pathak, Harsh B.
    Godwin, Andrew K.
    Petersen, Shariska
    Khabele, Dineo
    Roy, Jensen A.
    Dandawate, Prasad
    Weir, Scott J.
    Anant, Shrikant
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [48] TR3/NR4A1 as a therapeutic target for ovarian cancer.
    Beeghly-Fadiel, Alicia
    Chase, Dajah
    Cooks, Johnathan
    Crispens, Marta
    Khabele, Dineo
    Wilson, Andrew J.
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (15) : 61 - 61
  • [49] Fetal Microchimerism and Epithelial Ovarian Cancer.
    Liang, Kai Ling
    Mahmood, Uzma
    Yee, Fong Chui
    Lim, Diana
    Choolani, Mahesh
    O'Donoghue, Keelin
    [J]. REPRODUCTIVE SCIENCES, 2013, 20 (S3) : 312A - 313A
  • [50] Early mortality in epithelial ovarian cancer.
    McMinn, Erin
    Nasioudis, Dimitrios
    Latif, Nawar A.
    Cory, Lori
    Ko, Emily Meichun
    Giuntoli, Robert
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17585 - E17585